Indexed In
- Open J Gate
- Genamics JournalSeek
- Academic Keys
- JournalTOCs
- China National Knowledge Infrastructure (CNKI)
- Ulrich's Periodicals Directory
- RefSeek
- Hamdard University
- EBSCO A-Z
- Directory of Abstract Indexing for Journals
- OCLC- WorldCat
- Publons
- Geneva Foundation for Medical Education and Research
- Euro Pub
- Google Scholar
Useful Links
Share This Page
Journal Flyer
Open Access Journals
- Agri and Aquaculture
- Biochemistry
- Bioinformatics & Systems Biology
- Business & Management
- Chemistry
- Clinical Sciences
- Engineering
- Food & Nutrition
- General Science
- Genetics & Molecular Biology
- Immunology & Microbiology
- Medical Sciences
- Neuroscience & Psychology
- Nursing & Health Care
- Pharmaceutical Sciences
Articles published in Journal of Stem Cell Research & Therapy have been cited by esteemed scholars and scientists all around the world. Journal of Stem Cell Research & Therapy has got h-index 26, which means every article in Journal of Stem Cell Research & Therapy has got 26 average citations.
Following are the list of articles that have cited the articles published in Journal of Stem Cell Research & Therapy.
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
Year wise published articles |
59 | 65 | 23 | 13 | 36 |
Year wise citations received |
351 | 405 | 380 | 349 | 319 |
| Journal total citations count | 3118 |
| Journal Impact Factor | 1.64 |
| Journal 5 years Impact Factor | 1.70 |
| Journal CiteScore | 11.56 |
| Journal h-index | 26 |
Important citations
Self-renewal capacity of double negative 3 (DN3) early thymocytes preserves thymus autonomous function but compromises the ?-selection checkpoint
Gene Editing of Hematopoietic Stem Cells: Hopes and Hurdles Toward Clinical Translation
Human Pluripotent Stem Cells and CRISPR-Cas9 Genome Editing to Model Diabetes
Re-educating immunity in respiratory allergies: the potential for hematopoietic stem cell-mediated gene therapy
Towards safe therapy for immunodeficiency
Update on clinical ex vivo hematopoietic stem cell gene therapy for inherited monogenic diseases
Innovative cell-based therapies and conditioning to cure RAG deficiency
Gene replacement of ?-globin with ?-globin restores hemoglobin balance in ?-thalassemia-derived hematopoietic stem and progenitor cells
An integrated transcriptional switch at the ?-selection checkpoint determines T cell survival, development and leukaemogenesis
Laboratory-scale lentiviral vector production and purification for enhanced ex vivo and in vivo genetic engineering
Preclinical development of autologous hematopoietic stem cell-based gene therapy for immune deficiencies: A journey from mouse cage to bed side
Advances in gene therapy for hematologic disease and considerations for transfusion medicine
Gene Editing for the Treatment of Primary Immunodeficiency Diseases
CRISPR-Cas9 Gene Editing of Hematopoietic Stem Cells from Patients with Friedreich's Ataxia
CRISPR-CAS9. El mayor avance en técnicas de edición genética requiere una reflexión ética.
Genome editing for blood disorders: state of the art and recent advances
CIRM alpha stem cell clinics: collaboratively addressing regenerative medicine challenges
Mouse models in hematopoietic stem cell gene therapy and genome editing
Thymocyte self-renewal and oncogenic risk in immunodeficient mouse models: relevance for human gene therapy clinical trials targeting haematopoietic stem cell …
Humanized mouse models reveal an immunologic classification of idiopathic CD4 lymphocytopenia subtypes